NASDAQ:CSIICardiovascular Systems Stock Price, Forecast & News

Cardiovascular Systems' stock was trading at $36.32 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CSII stock has decreased by 14.7% and is now trading at $30.99. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardiovascular Systems in the last year. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cardiovascular Systems.

Cardiovascular Systems is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Cardiovascular Systems.

Cardiovascular Systems Inc (NASDAQ:CSII) posted its quarterly earnings data on Tuesday, May, 5th. The medical device company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.09) by $0.01. The medical device company had revenue of $61.18 million for the quarter, compared to analysts' expectations of $64 million. Cardiovascular Systems had a negative return on equity of 7.36% and a negative net margin of 4.04%. View Cardiovascular Systems' earnings history.

7 analysts have issued 1-year target prices for Cardiovascular Systems' shares. Their forecasts range from $44.00 to $58.00. On average, they expect Cardiovascular Systems' share price to reach $48.14 in the next twelve months. This suggests a possible upside of 55.3% from the stock's current price. View analysts' price targets for Cardiovascular Systems.

Press coverage about CSII stock has trended negative on Wednesday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cardiovascular Systems earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned headlines about the medical device company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news about Cardiovascular Systems.

Cardiovascular Systems saw a decrease in short interest in June. As of June 15th, there was short interest totaling 1,130,000 shares, a decrease of 11.7% from the May 31st total of 1,280,000 shares. Based on an average daily trading volume, of 292,000 shares, the short-interest ratio is currently 3.9 days. Approximately 3.3% of the company's shares are sold short. View Cardiovascular Systems' Current Options Chain.

Some companies that are related to Cardiovascular Systems include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Steris (STE) and Masimo (MASI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardiovascular Systems investors own include AbbVie (ABBV), Gilead Sciences (GILD), Netflix (NFLX), Adobe (ADBE), Advanced Micro Devices (AMD), Activision Blizzard (ATVI), Medtronic (MDT), Pfizer (PFE), Procter & Gamble (PG) and Target (TGT).

Cardiovascular Systems trades on the NASDAQ under the ticker symbol "CSII."

Cardiovascular Systems' stock is owned by a variety of institutional and retail investors. Top institutional investors include Diversified Trust Co (0.04%). Company insiders that own Cardiovascular Systems stock include Alexander Rosenstein, Jeffrey S Points, Martha Goldberg Aronson, Sandra Sedo and Scott R Ward. View institutional ownership trends for Cardiovascular Systems.

CSII stock was bought by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have bought Cardiovascular Systems stock in the last two years include Martha Goldberg Aronson, and Scott R Ward. View insider buying and selling activity for Cardiovascular Systems.

Shares of CSII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CSII stock can currently be purchased for approximately $30.99.

Cardiovascular Systems has a market capitalization of $1.09 billion and generates $248.02 million in revenue each year. The medical device company earns $-250,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Cardiovascular Systems employs 652 workers across the globe.

The official website for Cardiovascular Systems is www.csi360.com.

Cardiovascular Systems' mailing address is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. The medical device company can be reached via phone at 651-259-1600 or via email at [email protected]